These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6320547)

  • 1. Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo.
    Raether W; Seidenath H
    Z Parasitenkd; 1984; 70(1):135-8. PubMed ID: 6320547
    [No Abstract]   [Full Text] [Related]  

  • 2. A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease.
    Araújo MS; Martins-Filho OA; Pereira ME; Brener Z
    J Antimicrob Chemother; 2000 Jun; 45(6):819-24. PubMed ID: 10837436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An experimental and clinical assay with ketoconazole in the treatment of Chagas disease.
    Brener Z; Cançado JR; Galvão LM; da Luz ZM; Filardi Lde S; Pereira ME; Santos LM; Cançado CB
    Mem Inst Oswaldo Cruz; 1993; 88(1):149-53. PubMed ID: 8246750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caerulomycin, an antifungal antibiotic with marked in vitro and in vivo activity against Entamoeba histolytica.
    Chatterjee DK; Raether W; Iyer N; Ganguli BN
    Z Parasitenkd; 1984; 70(5):569-73. PubMed ID: 6095553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vivo and in vitro susceptibility of Trypanosoma cruzi to ketoconazole].
    Rubiolo ER; Cano RC
    Rev Latinoam Microbiol; 1987; 29(4):395-401. PubMed ID: 3149794
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.
    Ghosh S; Chan JM; Lea CR; Meints GA; Lewis JC; Tovian ZS; Flessner RM; Loftus TC; Bruchhaus I; Kendrick H; Croft SL; Kemp RG; Kobayashi S; Nozaki T; Oldfield E
    J Med Chem; 2004 Jan; 47(1):175-87. PubMed ID: 14695831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole promotes parasitological cure of mice infected with Trypanosoma cruzi.
    McCabe RE; Remington JS; Araujo FG
    Trans R Soc Trop Med Hyg; 1987; 81(4):613-5. PubMed ID: 3127963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reactivation of Trypanosoma cruzi infection in patients with acquired immunodeficiency syndrome].
    Galhardo MC; Martins IA; Hasslocher-Moreno A; Xavier SS; Coelho JM; Junqueira AC; dos Santos RR
    Rev Soc Bras Med Trop; 1999; 32(3):291-4. PubMed ID: 10380569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro.
    Goad LJ; Berens RL; Marr JJ; Beach DH; Holz GG
    Mol Biochem Parasitol; 1989 Jan; 32(2-3):179-89. PubMed ID: 2494453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of fexinidazole (HOE 239) against experimental infections with Trypanosoma cruzi, trichomonads and Entamoeba histolytica.
    Raether W; Seidenath H
    Ann Trop Med Parasitol; 1983 Feb; 77(1):13-26. PubMed ID: 6411009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind test of metronidazole and tinidazole in the treatment of asymptomatic Entamoeba histolytica and Entamoeba hartmanni carriers.
    Spillmann R; Ayala SC; Sanchez CE
    Am J Trop Med Hyg; 1976 Jul; 25(4):549-51. PubMed ID: 183554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivity of Farnesyltransferase Inhibitors Against
    Probst A; Nguyen TN; El-Sakkary N; Skinner D; Suzuki BM; Buckner FS; Gelb MH; Caffrey CR; Debnath A
    Front Cell Infect Microbiol; 2019; 9():180. PubMed ID: 31192168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An evaluation of the therapeutic action of tinidazole suppositories in intestinal infections by Protozoa in children (author's transl)].
    Schenone H; Prieto R; Angulo M; Galdames M; Romero E; Villarroel F
    Bol Chil Parasitol; 1980; 35(1-2):2-5. PubMed ID: 6260126
    [No Abstract]   [Full Text] [Related]  

  • 14. Ketoconazole protects against infection with Trypanosoma cruzi in a murine model.
    McCabe RE; Araujo FG; Remington JS
    Am J Trop Med Hyg; 1983 Sep; 32(5):960-2. PubMed ID: 6312824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of bisamidines of 2,6-diaminoanthraquinone on Entamoeba histolytica infections in rats and hamsters.
    Burden EJ; Carvajal SG; Fabio PF; Fields TL; Lin YI; Murdock KC; Lang SA
    Experientia; 1979 Jan; 35(1):33-5. PubMed ID: 217714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunodiagnostic findings in sera of patients with leishmaniasis, Chagas' disease, malaria and amebiasis in endemic regions of Venezuela (author's transl)].
    Salfelder A; Mannweiler E
    Tropenmed Parasitol; 1981 Sep; 32(3):194-6. PubMed ID: 6285563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental amoebiasis and the development of anti-amoebic compounds.
    Neal RA
    Parasitology; 1983 Feb; 86 (Pt 1)():175-91. PubMed ID: 6300739
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of infections by Entamoeba histolytica and Giardia lamblia with different dosages of 100 mg tinidazole enteric coated tablets (author's transl)].
    Schenone H; Villarroel F; Schenone L; Galdames M; Romero E; Jiménez M
    Bol Chil Parasitol; 1979; 34(1-2):2-6. PubMed ID: 540079
    [No Abstract]   [Full Text] [Related]  

  • 19. Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection of mice against lethal infection with the organism.
    McCabe RE; Remington JS; Araujo FG
    J Infect Dis; 1984 Oct; 150(4):594-601. PubMed ID: 6092485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparasitic nitroimidazoles. 1. Some 2-styryl-5-nitroimidazoles.
    Ross WJ; Jamieson WB; McCowen MC
    J Med Chem; 1972 Oct; 15(10):1035-40. PubMed ID: 4341747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.